SARAH NAVARRE: Open Payments
NPI 1407411440 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 13 payments from 9 companies in 2025. Trend: 2023 $317 · 2024 $319 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $193 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $57 |
| AtriCure, Inc. | 2 | $44 |
| TerSera Therapeutics LLC | 1 | $28 |
| Genentech USA, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
Products named: LifeVest, AtriCure cryoICE Cryoablation System (CRYO2), Zoladex, Columvi, VERQUVO, NINLARO, IMBRUVICA, General - Vascular Intervention.
Industry payments across LA — which companies pay providers there.
